{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:33:51Z","timestamp":1780364031882,"version":"3.54.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ5\/04208"],"award-info":[{"award-number":["2019\/35\/B\/NZ5\/04208"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ7\/02122"],"award-info":[{"award-number":["2018\/31\/B\/NZ7\/02122"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This work presents a multifaceted mechanism of the anticancer action of a 2-styrylquinazoline derivative. Extensive analysis of various aspects related to tyrosine kinase inhibition and effects on cellular targets at both the gene and protein levels revealed the potential of this IS20 compound for future research. This study presents a detailed analysis of the relationship between ABL and SRC kinase affecting the inhibition of the EGFR\/mTOR signaling pathway in a non-obvious manner. The study was supported by experiments using various molecular biology techniques to confirm the induction of oxidative stress, inhibition of the cell cycle in the G2\/M phase and the triggering of cell death via both the apoptosis and autophagy pathways. The cell models included those with different p53 protein status, which affected the cellular response in the form of altered <jats:italic>Ndrg1<\/jats:italic> expression. Finally, the appropriate physicochemical properties of IS20 for adequate bioavailability and toxicity to the body were observed in an <jats:italic>in vivo<\/jats:italic> model.<\/jats:p>","DOI":"10.1038\/s41598-025-99277-1","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:15:50Z","timestamp":1746706550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unveiling the role of Ndrg1 gene on the oxidative stress induction behind the anticancer potential of styrylquinazoline derivatives"],"prefix":"10.1038","volume":"15","author":[{"given":"Katarzyna","family":"Malarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kuczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Rurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Rawicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Boguszewska-Czubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Jampilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Mularski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Musiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mrozek-Wilczkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"99277_CR1","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.bmc.2010.02.025","volume":"18","author":"A Mrozek-Wilczkiewicz","year":"2010","unstructured":"Mrozek-Wilczkiewicz, A. et al. Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones. Bioorg. Med. Chem. 18, 2664\u20132671 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"99277_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2019.03.004","volume":"170","author":"D Das","year":"2019","unstructured":"Das, D. & Hong, J. Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. Eur. J. Med. Chem. 170, 55\u201372 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR3","doi-asserted-by":"crossref","unstructured":"Musiol, R. et al. Investigating the Activity Spectrum for Ring-Substituted 8-Hydroxyquinolines.Molecules15, 288\u2013304. (2010).","DOI":"10.3390\/molecules15010288"},{"key":"99277_CR4","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1016\/j.bmcl.2004.07.065","volume":"14","author":"PM Bedi","year":"2004","unstructured":"Bedi, P. M., Kumar, V. & Mahajan, M. P. Synthesis and biological activity of novel antibacterial Quinazolines. Bioorg. Med. Chem. Lett. 14, 5211\u20135213 (2004).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"99277_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1747-0285.2007.00548.x","volume":"70","author":"V Alagarsamy","year":"2007","unstructured":"Alagarsamy, V. et al. Synthesis of novel 3-butyl-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents. Chem. Biol. Drug Des. 70, 254\u2013260 (2007).","journal-title":"Chem. Biol. Drug Des."},{"key":"99277_CR6","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/ncomms15071","volume":"8","author":"FE Held","year":"2017","unstructured":"Held, F. E. et al. Facile access to potent antiviral Quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions. Nat. Commun. 8, 15071 (2017).","journal-title":"Nat. Commun."},{"key":"99277_CR7","doi-asserted-by":"crossref","unstructured":"Lee, J. Y., Park, J. H., Lee, S. J., Park, H. & Lee, Y. S. Styrylquinazoline derivatives as HIV-1 integrase inhibitors. Arch. Pharm., 335 (2002).","DOI":"10.1002\/1521-4184(200208)335:6<277::AID-ARDP277>3.0.CO;2-A"},{"key":"99277_CR8","doi-asserted-by":"crossref","unstructured":"Hricoviniova, J., Hricoviniova, Z. & Kozics, K. Antioxidant, cytotoxic,genotoxic, and DNA-Protective potential of 2,3-Substituted Quinazolinones: Structure-Activity relationship study. Int. J. Mol. Sci., 22 (2021).","DOI":"10.3390\/ijms22020610"},{"key":"99277_CR9","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.3390\/molecules14104246","volume":"14","author":"J Jampilek","year":"2009","unstructured":"Jampilek, J. et al. Investigating biological activity spectrum for novel styrylquinazoline analogues. Molecules 14, 4246\u20134265 (2009).","journal-title":"Molecules"},{"key":"99277_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1039\/C7MD00097A","volume":"8","author":"S Shagufta","year":"2017","unstructured":"Shagufta, S. & Ahmad, I. An insight into the therapeutic potential of Quinazoline derivatives as anticancer agents. MedChemComm 8, 871\u2013885 (2017).","journal-title":"MedChemComm"},{"key":"99277_CR11","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1038\/sj.onc.1207198","volume":"22","author":"J Wischhusen","year":"2003","unstructured":"Wischhusen, J., Naumann, U., Ohgaki, H., Rastinejad, F. & Weller, M. CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 22, 8233\u20138245 (2003).","journal-title":"Oncogene"},{"key":"99277_CR12","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/sj.onc.1205362","volume":"21","author":"TM Rippin","year":"2002","unstructured":"Rippin, T. M. et al. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells. Oncogene 21, 2119\u20132129 (2002).","journal-title":"Oncogene"},{"key":"99277_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ejmech.2018.12.012","volume":"163","author":"J Mularski","year":"2019","unstructured":"Mularski, J., Malarz, K., Pacholczyk, M. & Musiol, R. The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series. Eur. J. Med. Chem. 163, 610\u2013625 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR14","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.bmc.2017.03.048","volume":"25","author":"D Zhou","year":"2017","unstructured":"Zhou, D. et al. Small molecules inhibit STAT3 activation, autophagy, and cancer cell anchorage-independent growth. Bioorg. Med. Chem. 25, 2995\u20133005 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"99277_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/cmdc.201600636","volume":"12","author":"D Xu","year":"2017","unstructured":"Xu, D. et al. Structure-Based Target-Specific screening leads to Small-Molecule camkii inhibitors. ChemMedChem 12, 660\u2013677 (2017).","journal-title":"ChemMedChem"},{"key":"99277_CR16","doi-asserted-by":"publisher","first-page":"111851","DOI":"10.1016\/j.ejmech.2019.111851","volume":"186","author":"XW Wei","year":"2020","unstructured":"Wei, X. W. et al. Su, 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents. Eur. J. Med. Chem. 186, 111851 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1021\/acsmedchemlett.1c00004","volume":"12","author":"M Dvorakova","year":"2021","unstructured":"Dvorakova, M. et al. Synthesis, inhibitory activity, and in Silico modeling of selective COX-1 inhibitors with a Quinazoline core. ACS Med. Chem. Lett. 12, 610\u2013616 (2021).","journal-title":"ACS Med. Chem. Lett."},{"key":"99277_CR18","doi-asserted-by":"publisher","first-page":"2201410","DOI":"10.1080\/14756366.2023.2201410","volume":"38","author":"K Malarz","year":"2023","unstructured":"Malarz, K., Mularski, J., Pacholczyk, M. & Musiol, R. Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations. J. Enzyme Inhib. Med. Chem. 38, 2201410 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"99277_CR19","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3390\/cancers13081790","volume":"13","author":"K Malarz","year":"2021","unstructured":"Malarz, K., Mularski, J., Kuczak, M., Mrozek-Wilczkiewicz, A. & Musiol, R. Novel benzenesulfonate scaffolds with a high anticancer activity and G2\/M cell cycle arrest. Cancers. 13, 1790 (2021).","journal-title":"Cancers (Basel)"},{"key":"99277_CR20","doi-asserted-by":"publisher","first-page":"23780","DOI":"10.18632\/oncotarget.25267","volume":"9","author":"FM Simabuco","year":"2018","unstructured":"Simabuco, F. M. et al. p53 and metabolism: from mechanism to therapeutics. Oncotarget 9, 23780\u201323823 (2018).","journal-title":"Oncotarget"},{"key":"99277_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1947601911408889","volume":"2","author":"N Rivlin","year":"2011","unstructured":"Rivlin, N., Brosh, R., Oren, M. & Rotter, V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2, 466\u2013474 (2011).","journal-title":"Genes Cancer"},{"key":"99277_CR22","doi-asserted-by":"crossref","unstructured":"Liu, D., Xu, Y. & Aging p53, Oxidative Stress, and Antioxid. Redox. Signal., 15 1669\u20131678. (2011).","DOI":"10.1089\/ars.2010.3644"},{"key":"99277_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/OTT.S215997","volume":"15","author":"M Niedbala","year":"2022","unstructured":"Niedbala, M., Malarz, K., Sharma, G., Kramer-Marek, G. & Kaspera, W. Glioblastoma: pitfalls and opportunities of immunotherapeutic combinations. Onco Targets Ther. 15, 437\u2013468 (2022).","journal-title":"Onco Targets Ther."},{"key":"99277_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research","year":"2008","unstructured":"Cancer Genome Atlas Research. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"99277_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/PO.20.00519","volume":"5","author":"Y Pang","year":"2021","unstructured":"Pang, Y. et al. Report of canonical BCR-ABL1 fusion in glioblastoma. JCO Precis. Oncol. 5, 1348\u20131353 (2021).","journal-title":"JCO Precis Oncol."},{"key":"99277_CR26","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/1878-0261.13157","volume":"16","author":"V Palande","year":"2022","unstructured":"Palande, V. et al. Detection of gene mutations and gene\u2013gene fusions in Circulating cell\u2010free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. Mol. Oncol. 16, 2098\u20132114 (2022).","journal-title":"Mol. Oncol."},{"key":"99277_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-017-2676-5","volume":"136","author":"E Goethe","year":"2018","unstructured":"Goethe, E., Carter, B. Z., Rao, G. & Pemmaraju, N. Glioblastoma and acute myeloid leukemia: malignancies with striking similarities. J. Neurooncol. 136, 223\u2013231 (2018).","journal-title":"J. Neurooncol"},{"key":"99277_CR28","doi-asserted-by":"crossref","unstructured":"Nie, Y., Li, H. H., Bula, C. M. & Liu, X. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization. Mol. Cell. Biol. 20 741\u2013748. (2000).","DOI":"10.1128\/MCB.20.3.741-748.2000"},{"key":"99277_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z","volume":"79","author":"M Weller","year":"1998","unstructured":"Weller, M. et al. Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int. J. Cancer. 79, 640\u2013644 (1998).","journal-title":"Int. J. Cancer"},{"key":"99277_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","volume":"17","author":"JC Law","year":"1993","unstructured":"Law, J. C., Ritke, M. K., Yalowich, J. C., Leder, G. H. & Ferrell, R. E. Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line. Leuk. Res. 17, 1045\u20131050 (1993).","journal-title":"Leuk. Res."},{"key":"99277_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gad.190678.112","volume":"26","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor, W. A. & Prives, C. Mutant p53: one name, many proteins. Genes Dev. 26, 1268\u20131286 (2012).","journal-title":"Genes Dev."},{"key":"99277_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/cancers12030536","volume":"12","author":"K Malarz","year":"2020","unstructured":"Malarz, K., Mularski, J., Pacholczyk, M. & Musiol, R. The landscape of the Anti-Kinase activity of the IDH1 inhibitors. Cancers. 12, 536 (2020).","journal-title":"Cancers (Basel)"},{"key":"99277_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579\u2013591 (2009).","journal-title":"Nat. Rev. DrugDiscov"},{"key":"99277_CR34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","volume":"22","author":"Z Zou","year":"2017","unstructured":"Zou, Z., Chang, H., Li, H. & Wang, S. Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis 22, 1321\u20131335 (2017).","journal-title":"Apoptosis"},{"key":"99277_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo, B. et al. ROS in cancer therapy: the bright side of the Moon. Exp. Mol. Med. 52, 192\u2013203 (2020).","journal-title":"Exp. Mol. Med."},{"key":"99277_CR36","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.18632\/oncotarget.24844","volume":"9","author":"K Malarz","year":"2018","unstructured":"Malarz, K. et al. The role of oxidative stress in activity of anticancer thiosemicarbazones. Oncotarget 9, 17689\u201317710 (2018).","journal-title":"Oncotarget"},{"key":"99277_CR37","doi-asserted-by":"crossref","unstructured":"Malarz, K., Zych, D., Gawecki, R., Kuczak, M. & Musio\u0142, R. A. Mrozek-Wilczkiewicz, New derivatives of 4\u2019-phenyl-2,2\u2019:6\u2019,2\u2033-terpyridine as promising anticancer agents. Eur. J. Med. Chem., 113032. (2020).","DOI":"10.1016\/j.ejmech.2020.113032"},{"key":"99277_CR38","doi-asserted-by":"publisher","first-page":"112039","DOI":"10.1016\/j.ejmech.2020.112039","volume":"189","author":"K Malarz","year":"2020","unstructured":"Malarz, K., Zych, D., Kuczak, M., Musio\u0142, R. & Mrozek-Wilczkiewicz, A. Anticancer activity of 4\u2019-phenyl-2,2\u2019:6\u2019,2\u2033-terpyridines - behind the metal complexation. Eur. J. Med. Chem. 189, 112039 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejmech.2019.03.027","volume":"171","author":"A Mrozek-Wilczkiewicz","year":"2019","unstructured":"Mrozek-Wilczkiewicz, A., Malarz, K., Rejmund, M., Polanski, J. & Musiol, R. Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and Quinoline moiety. Eur. J. Med. Chem. 171, 180\u2013194 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR40","doi-asserted-by":"publisher","first-page":"65889","DOI":"10.18632\/oncotarget.19508","volume":"8","author":"Y Arihara","year":"2017","unstructured":"Arihara, Y. et al. Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma. Oncotarget 8, 65889\u201365899 (2017).","journal-title":"Oncotarget"},{"key":"99277_CR41","first-page":"79","volume":"9","author":"B Zhong","year":"2019","unstructured":"Zhong, B. et al. A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2\/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. Am. J. Cancer Res. 9, 79\u201393 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"99277_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ccr.2017.11.020","volume":"357","author":"G Sivaraman","year":"2018","unstructured":"Sivaraman, G. et al. Chemically diverse small molecule fluorescent chemosensors for copper ion. Coord. Chem. Rev. 357, 50\u2013104 (2018).","journal-title":"Coord. Chem. Rev."},{"key":"99277_CR43","doi-asserted-by":"publisher","first-page":"e6475","DOI":"10.1002\/aoc.6475","volume":"36","author":"LQ Chai","year":"2022","unstructured":"Chai, L. Q., Chai, Y. M., Li, C. G. & Zhou, L. Two mono- and dinuclear Cu (II) complexes derived from 3-ethoxy salicylaldehyde: X-ray structures, spectroscopic, electrochemical, antibacterial activities, Hirshfeld surfaces analyses, and time-dependent density functional theory studies. Appl. Organomet. Chem. 36, e6475 (2022).","journal-title":"Appl. Organomet. Chem."},{"key":"99277_CR44","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1039\/C8NJ02011F","volume":"42","author":"S Sarkar","year":"2018","unstructured":"Sarkar, S. et al. A multi-responsive thiosemicarbazone-based probe for detection and discrimination of group 12 metal ions and its application in logic gates. New. J. Chem. 42, 15157\u201315169 (2018).","journal-title":"New. J. Chem."},{"key":"99277_CR45","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/cdd.2009.107","volume":"16","author":"R Franco","year":"2009","unstructured":"Franco, R. & Cidlowski, J. A. Apoptosis and glutathione: beyond an antioxidant.Cell. Death Differ. 16, 1303\u20131314 (2009).","journal-title":"Cell. Death Differ."},{"key":"99277_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","volume":"54","author":"OM Ighodaro","year":"2018","unstructured":"Ighodaro, O. M. & Akinloye, O. A. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alex. J. Med. 54, 287\u2013293 (2018).","journal-title":"Alexandria J. Med."},{"key":"99277_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0891-5849(99)00223-3","volume":"28","author":"SW Ryter","year":"2000","unstructured":"Ryter, S. W. & Tyrrell, R. M. The Heme synthesis and degradation pathways: role in oxidant sensitivity. Heme Oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 28, 289\u2013309 (2000).","journal-title":"Free Radic Biol. Med."},{"key":"99277_CR48","doi-asserted-by":"crossref","unstructured":"Chau, L. Y. Heme oxygenase-1: emerging target of cancer therapy. J. Biomed. Sci., 22 (2015).","DOI":"10.1186\/s12929-015-0128-0"},{"key":"99277_CR49","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/cells10092401","volume":"10","author":"SK Chiang","year":"2021","unstructured":"Chiang, S. K., Chen, S. E. & Chang, L. C. The role of HO-1 and its crosstalk with oxidative stress in Cancer cell survival. Cells 10, 2401 (2021).","journal-title":"Cells"},{"key":"99277_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejmech.2019.05.061","volume":"177","author":"A Mrozek-Wilczkiewicz","year":"2019","unstructured":"Mrozek-Wilczkiewicz, A. et al. The synthesis and anticancer activity of 2-styrylquinoline derivatives. A p53 independent mechanism of action. Eur. J. Med. Chem. 177, 338\u2013349 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"99277_CR51","first-page":"1","volume":"1845","author":"BA Fang","year":"2014","unstructured":"Fang, B. A. et al. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochim. Biophys. Acta. 1845, 1\u201319 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"99277_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/brainsci12040473","volume":"12","author":"Y Nakahara","year":"2022","unstructured":"Nakahara, Y. et al. A tumor suppressor gene, N-myc Downstream-Regulated gene 1 (NDRG1), in gliomas and glioblastomas. Brain Sci. 12, 473 (2022).","journal-title":"Brain Sci."},{"key":"99277_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11060-009-9859-7","volume":"94","author":"B Sun","year":"2009","unstructured":"Sun, B. et al. Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J. Neurooncol. 94, 213\u2013219 (2009).","journal-title":"J. Neurooncol."},{"key":"99277_CR54","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.1074\/jbc.R117.776393","volume":"292","author":"SV Menezes","year":"2017","unstructured":"Menezes, S. V., Sahni, S., Kovacevic, Z. & Richardson, D. R. Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling. J. Biol. Chem. 292, 12772\u201312782 (2017).","journal-title":"J. Biol. Chem."},{"key":"99277_CR55","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1074\/jbc.M112.350470","volume":"287","author":"Z Chen","year":"2012","unstructured":"Chen, Z. et al. The Iron chelators Dp44mT and DFO inhibit TGF-\u03b2-induced Epithelial-Mesenchymal transition via Up-Regulation of N-Myc Downstream-regulated gene 1 (NDRG1). J. Biol. Chem. 287, 17016\u201317028 (2012).","journal-title":"J. Biol. Chem."},{"key":"99277_CR56","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","volume":"104","author":"NTV Le","year":"2004","unstructured":"Le, N. T. V. & Richardson, D. R. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 104, 2967\u20132975 (2004).","journal-title":"Blood"},{"key":"99277_CR57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/ars.2014.5851","volume":"21","author":"SS Cao","year":"2014","unstructured":"Cao, S. S. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 21, 396\u2013413 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"99277_CR58","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.bbadis.2019.04.007","volume":"1865","author":"AM Merlot","year":"2019","unstructured":"Merlot, A. M. et al. The metastasis suppressor, NDRG1, differentially modulates the Endoplasmic reticulum stress response. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2094\u20132110 (2019).","journal-title":"Biochim. Biophys. Acta Mol. BasisDis."},{"key":"99277_CR59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.138.3.547","volume":"138","author":"M Waser","year":"1997","unstructured":"Waser, M., Mesaeli, N., Spencer, C. & Michalak, M. Regulation of calreticulin gene expression by calcium. J. Cell Biol. 138, 547\u2013557 (1997).","journal-title":"J. Cell Biol."},{"key":"99277_CR60","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1074\/jbc.RA118.005166","volume":"294","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. The ER-localized Ca2+-binding protein calreticulin couples ER stress to autophagy by associating with microtubule-associated protein 1A\/1B light chain 3. J. Biol. Chem. 294, 772\u2013782 (2019).","journal-title":"J. Biol. Chem."},{"key":"99277_CR61","doi-asserted-by":"publisher","first-page":"9692","DOI":"10.1074\/jbc.M113.529511","volume":"289","author":"S Sahni","year":"2014","unstructured":"Sahni, S. et al. The metastasis suppressor, N-myc Downstream-regulated gene 1 (NDRG1), inhibits Stress-induced autophagy in Cancer cells. J. Biol. Chem. 289, 9692\u20139709 (2014).","journal-title":"J. Biol. Chem."},{"key":"99277_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20061638","volume":"402","author":"N Pollak","year":"2007","unstructured":"Pollak, N., Dolle, C. & Ziegler, M. The power to reduce: pyridine nucleotides\u2013small molecules with a multitude of functions. Biochem. J. 402, 205\u2013218 (2007).","journal-title":"Biochem. J."},{"key":"99277_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2015.05.003","volume":"152","author":"SJ Parker","year":"2015","unstructured":"Parker, S. J. & Metallo, C. M. Metabolic consequences of oncogenic IDH mutations. Pharmacol. Ther. 152, 54\u201362 (2015).","journal-title":"Pharmacol. Ther."},{"key":"99277_CR64","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10072-013-1607-2","volume":"35","author":"J Shi","year":"2014","unstructured":"Shi, J. et al. An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation. Neurol. Sci. 35, 839\u2013845 (2014).","journal-title":"Neurol. Sci."},{"key":"99277_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1074\/jbc.M115.689653","volume":"291","author":"Z Kovacevic","year":"2016","unstructured":"Kovacevic, Z. et al. The metastasis suppressor, N-MYC downstream-regulated Gene-1 (NDRG1), Down-regulates the erbb family of receptors to inhibit downstream oncogenic signaling pathways. J. Biol. Chem. 291, 1029\u20131052 (2016).","journal-title":"J. Biol. Chem."},{"key":"99277_CR66","doi-asserted-by":"crossref","unstructured":"Liu, W. et al. The proto-oncogene c-Src and its Downstream Signaling Pathways Are Inhibited by the Metastasis Suppressor, NDRG1  Oncotarget, 68851\u20138874 (2015).","DOI":"10.18632\/oncotarget.3316"},{"key":"99277_CR67","doi-asserted-by":"crossref","unstructured":"Hwang, B., Engel, L., Goueli, S. A. & Zegzouti, H. A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation. Commun. Biol. 3 (2020).","DOI":"10.1038\/s42003-019-0723-9"},{"key":"99277_CR68","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/0008-5472.CAN-19-0438","volume":"80","author":"H Ito","year":"2020","unstructured":"Ito, H. et al. Bidirectional regulation between NDRG1 and GSK3\u03b2 controls tumor growth and is targeted by differentiation inducing Factor-1 in glioblastoma. Cancer Res. 80, 234\u2013248 (2020).","journal-title":"Cancer Res."},{"key":"99277_CR69","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3892\/mmr.2015.3492","volume":"12","author":"W Ma","year":"2015","unstructured":"Ma, W., Na, M., Tang, C., Wang, H. & Lin, Z. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase\/AKT pathways. Mol. Med. Rep. 12, 1050\u20131058 (2015).","journal-title":"Mol. Med. Rep."},{"key":"99277_CR70","doi-asserted-by":"crossref","unstructured":"Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1\/MEKK4 MAPKKK, Cell. 95, 521\u2013530. (1998).","DOI":"10.1016\/S0092-8674(00)81619-0"},{"key":"99277_CR71","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/carcin\/bgr046","volume":"32","author":"Z Kovacevic","year":"2011","unstructured":"Kovacevic, Z. et al. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms. Carcinogenesis 32, 732\u2013740 (2011).","journal-title":"Carcinogenesis"},{"key":"99277_CR72","doi-asserted-by":"publisher","first-page":"39544","DOI":"10.18632\/oncotarget.9647","volume":"7","author":"AM Schlafli","year":"2016","unstructured":"Schlafli, A. M. et al. Prognostic value of the autophagy markers LC3 and p62\/SQSTM1 in early-stage non-small cell lung cancer. Oncotarget 7, 39544\u201339555 (2016).","journal-title":"Oncotarget"},{"key":"99277_CR73","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.dib.2016.02.085","volume":"7","author":"R Gomez-Sanchez","year":"2016","unstructured":"Gomez-Sanchez, R. et al. Gonzalez-Polo, mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines. Data Brief. 7, 641\u2013647 (2016).","journal-title":"Data Brief."},{"key":"99277_CR74","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10571-015-0166-x","volume":"35","author":"L Li","year":"2015","unstructured":"Li, L., Tan, J., Miao, Y., Lei, P. & Zhang, Q. ROS and autophagy: interactions and molecular regulatory mechanisms. Cell. Mol. Neurobiol. 35, 615\u2013621 (2015).","journal-title":"Cell. Mol. Neurobiol."},{"key":"99277_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C. & Guan, K. L. mTOR: a Pharmacologic target for autophagy regulation. J. Clin. Invest. 125, 25\u201332 (2015).","journal-title":"J. Clin. Invest."},{"key":"99277_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0300-9084(02)01374-3","volume":"84","author":"C Cande","year":"2002","unstructured":"Cande, C. et al. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84, 215\u2013222 (2002).","journal-title":"Biochimie"},{"key":"99277_CR77","first-page":"81","volume":"22","author":"J Usuda","year":"2003","unstructured":"Usuda, J. et al. Restoration of p53 gene function in 12-O-tetradecanoylphorbor 13-acetate-resistant human leukemia K562\/TPA cells. Int. J. Oncol. 22, 81\u201386 (2003).","journal-title":"Int. J. Oncol."},{"key":"99277_CR78","doi-asserted-by":"publisher","first-page":"e13071","DOI":"10.1111\/bpa.13071","volume":"32","author":"J Ni","year":"2022","unstructured":"Ni, J., Lan, F., Xu, Y., Nakanishi, H. & Li, X. Extralysosomal cathepsin B in central nervous system: mechanisms and therapeutic implications. Brain Pathol. 32, e13071 (2022).","journal-title":"Brain Pathol."},{"key":"99277_CR79","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41419-023-05786-0","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie, Z. et al. Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways. Cell. Death Dis. 14, 255 (2023).","journal-title":"Cell. Death Dis."},{"key":"99277_CR80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/ncb866","volume":"4","author":"JK Sax","year":"2002","unstructured":"Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E. & Korsmeyer, S. J. El-Deiry, BID regulation by p53 contributes to chemosensitivity. Nat. Cell. Biol. 4, 842\u2013849 (2002).","journal-title":"Nat. Cell. Biol."},{"key":"99277_CR81","doi-asserted-by":"crossref","unstructured":"Kerns, E. H., Di, L. & Properties, D. L. Concepts. Structure Design and Methods: from ADME To Toxicity Optimization (Academic, 2008).","DOI":"10.1016\/B978-012369520-8.50018-8"},{"key":"99277_CR82","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger, A., Gon\u00e7alves Maltarollo, V., Wrenger, C. & Kronenberger, T. ADME Profiling in Drug Discovery and a New Path Paved on Silica (In: Drug Discovery and Development - New Advances, 2020).","DOI":"10.5772\/intechopen.86174"},{"key":"99277_CR83","doi-asserted-by":"crossref","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1PII of original article: S0169-409X(96)00423-1. Adv. Drug Deliv. Rev. 46 (2001) 3\u201326. (1997).","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"99277_CR84","first-page":"721","volume":"12","author":"DG Jimenez","year":"2024","unstructured":"Jimenez, D. G. et al. Molecular properties, including chameleonicity, as essential tools for designing the next generation of oral beyond rule of five drugs. ADMET DMPK. 12, 721\u2013736 (2024).","journal-title":"ADMET DMPK"},{"key":"99277_CR85","doi-asserted-by":"crossref","unstructured":"Avdeef, A. Often neglected steps in transforming drug solubility from single measurement in pure water to physiologically-appropriate solubility-pH. ADMET DMPK, 13 (2025).","DOI":"10.5599\/admet.2626"},{"key":"99277_CR86","doi-asserted-by":"crossref","unstructured":"Jampilek, J. & Kralova, K. Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. Pharmaceutics 14, 2706. (2022).","DOI":"10.3390\/pharmaceutics14122706"},{"key":"99277_CR87","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/B978-0-12-374194-3.00022-6","volume-title":"The Practice of Medicinal Chemistry","author":"CA Lipinski","year":"2008","unstructured":"Lipinski, C. A. Compound properties and drug quality. In: (ed Wermuth, C. G.) The Practice of Medicinal Chemistry. Academic, New York, 481\u2013490. (2008)."},{"key":"99277_CR88","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R. & Ward, K. W. Kopple, molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"99277_CR89","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10822-011-9478-1","volume":"25","author":"M Muehlbacher","year":"2011","unstructured":"Muehlbacher, M., Spitzer, G. M., Liedl, K. R. & Kornhuber, J. Qualitative prediction of blood\u2013brain barrier permeability on a large and refined dataset. J. Comput. Aided Mol. Des. 25, 1095\u20131106 (2011).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"99277_CR90","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bpj.2014.06.024","volume":"107","author":"S Carpenter","year":"2014","unstructured":"Carpenter, S. et al. Felice, A method to predict Blood-Brain barrier permeability of Drug-Like compounds using molecular dynamics simulations. Biophys. J. 107, 630\u2013641 (2014).","journal-title":"Biophys. J."},{"key":"99277_CR91","first-page":"1","volume":"11","author":"V Chunduri","year":"2023","unstructured":"Chunduri, V. & Maddi, S. Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review. ADMET DMPK. 11, 1\u201332 (2023).","journal-title":"ADMET DMPK"},{"key":"99277_CR92","doi-asserted-by":"publisher","first-page":"43599","DOI":"10.1007\/s11356-020-10800-5","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen, C. & Zuo, Z. Zebrafish (Danio rerio) as an excellent vertebrate model for the development, reproductive, cardiovascular, and neural and ocular development toxicity study of hazardous chemicals. Environ. Sci. Pollut. Res. Int. 27, 43599\u201343614 (2020).","journal-title":"Environ. Sci. Pollut Res. Int."},{"key":"99277_CR93","doi-asserted-by":"publisher","first-page":"116023","DOI":"10.1016\/j.ecoenv.2024.116023","volume":"272","author":"W Zhao","year":"2024","unstructured":"Zhao, W., Chen, Y., Hu, N., Long, D. & Cao, Y. The uses of zebrafish (Danio rerio) as an in vivo model for toxicological studies: A review based on bibliometrics. Ecotoxicol. Environ. Saf. 272, 116023 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"99277_CR94","doi-asserted-by":"publisher","first-page":"4","DOI":"10.20517\/2572-8180.2017.15","volume":"3","author":"MV Caballero","year":"2018","unstructured":"Caballero, M. V. & Candiracci, M. Zebrafish as toxicological model for screening and recapitulate human diseases. J. Unexplored Med. Data. 3, 4 (2018).","journal-title":"J. Unexplored Med. Data"},{"key":"99277_CR95","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/nprot.2006.378","volume":"1","author":"I Rahman","year":"2006","unstructured":"Rahman, I., Kode, A. & Biswas, S. K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 1, 3159\u20133165 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99277-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:03:00Z","timestamp":1746709380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99277-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99277-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16081"}}